PRP vs PRF: What's the Difference for Nurses?

PRP and PRF look almost identical on a treatment menu, and a lot of nurses use the terms interchangeably — which tells me their training didn't explain the difference. It's a real and useful one. I run both in my own practice, and the distinction comes down to one decision made at the very start of the preparation that changes how the product behaves in the tissue. Here's the honest, practical comparison: what separates PRP from PRF, what each is best for, and which a nurse should learn first.

The core difference is the anticoagulant — and what that changes downstream. PRP (platelet-rich plasma) is prepared *with* an anticoagulant and typically a faster, often double-spin protocol, giving you a concentrated liquid you inject. PRF (platelet-rich fibrin) is prepared *without* anticoagulant and at a slower, gentler spin, so the blood begins to clot and forms a fibrin scaffold that traps platelets and white cells and releases growth factors more slowly over time. PRP delivers a fast, concentrated hit; PRF trades peak concentration for a slow-release matrix.

*This is general educational guidance, not a clinical protocol to apply without proper hands-on training and supervision.*

Here's the same comparison at a glance:

It starts at the tube and the spin. For PRP, the draw uses an anticoagulant so the blood stays liquid, then it's concentrated — and the concentration is the whole game. A single-spin protocol can't reach a therapeutic, supraphysiologic platelet load; a double-spin protocol can. For PRF, you skip the anticoagulant and use a slower, lower-speed spin, which lets natural clotting build a fibrin network. That network is the point: it physically holds the platelets and releases their growth factors gradually instead of all at once. Same blood, two different preparation philosophies, two different behaviors in the tissue. (The full PRP concentration method — spin protocol, LR vs LP, indication-specific prep — is in our canonical PRP training guide.)

PRF shines where you want a slower, sustained release and a more cohesive, gel-like product. The fibrin scaffold makes PRF useful in settings where holding the growth factors in place over time matters more than peak concentration up front. Its consistency also lets it be used in forms that liquid PRP can't take. The trade-off is that you give up some of the immediate concentrated load that PRP's double-spin delivers — so the choice is genuinely indication-dependent, not "one is better."

PRF also isn't one single thing. You'll see a solid, clot-like form and a liquid form often called i-PRF (injectable PRF). The liquid version is spun briefly so it stays injectable for a short window before it gels, which makes it easier to deliver through a needle while keeping the no-anticoagulant, slow-release character that defines PRF. Same family, two physical forms — and knowing which one a case calls for is part of using PRF well.

PRP is the tool when you want a high, concentrated growth-factor load delivered to the target — and when you want the control that comes from a double-spin, indication-tuned preparation. Because you can dial the concentration and tailor the draw volume and prep to the indication (a facial microneedling application, a scalp injection, and a joint injection are not the same preparation), PRP gives you more flexibility to match the treatment to the case. It's the workhorse of a regenerative menu and the better place to build your core regenerative competence.

Let me correct a common marketing claim here, because it's worth your time as a clinician. You'll see pages position PRF as the better tear-trough choice and imply it "fills" or adds volume under the eye. I don't teach that, and I don't believe the evidence supports it. Neither PRP nor PRF is a volumizer. Any fullness you see in the days after treatment is swelling, not a placed volume result — and because it was never volume to begin with, the "how long does the volume last" question doesn't apply. We use PRP and PRF in the periorbital area for their regenerative and skin-quality effect: improving texture, tone, and the quality of thin under-eye skin over a series of treatments. That's the honest indication. If a patient needs actual volume in the tear trough, that's a different conversation (and a different tool) — don't let a growth-factor product be sold as something it isn't. And regardless of which you use, the under-eye is a high-skill, high-risk zone: get hands-on training before you treat it.

"Lasts longer" is the wrong frame, and it's worth retraining yourself out of it. The slow-release fibrin scaffold in PRF is real, but neither PRP nor PRF is a volumizer the way a filler or fat is — so there's no placed volume to "last." Both work by stimulating your own tissue, which means the result you care about is the regenerative effect you trigger over a treatment series, not a product sitting in place. I won't give you a "PRF lasts X months longer" number, because that number describes a volumizing claim neither product earns. Set the patient's expectation around skin quality and a course of treatments, not around a result that wears off.

Learn PRP first. It teaches the regenerative fundamentals that everything else leans on — the science of concentration, the spin protocol, indication-specific preparation, and the LR-PRP vs LP-PRP decision. Once you genuinely understand *why* concentration and preparation drive results, PRF is a much smaller step: it's the same blood with one preparation decision changed. A nurse who masters PRP can reason about PRF; a nurse who only memorized one PRF recipe can't reason about either. (For where both fit in the broader sequence, see where to start with regenerative aesthetics.)

Yes, in most states. RNs inject in all 50 states, and the blood draw, preparation, and injection of PRP or PRF fall within nursing scope when you're properly trained. Ordering or prescribing the treatment plan falls to an NP, MD, or DO. This is one of the more nurse-accessible corners of regenerative aesthetics — it doesn't hinge on prescriptive authority the way the longevity lane does. Confirm your state's specifics and supervision rules with your board.

*Typical results vary, and regenerative outcomes depend on the patient, the indication, and the preparation. Nothing here is a guarantee of results.*